HEGDE SHARATHCHANDRA S 4
4 · Theravance Biopharma, Inc. · Filed May 16, 2018
Insider Transaction Report
Form 4
HEGDE SHARATHCHANDRA S
SVP, Research
Transactions
- Award
Ordinary Shares
2018-05-14+33,750→ 193,361 total
Footnotes (1)
- [F1]On March 15, 2016, the reporting person was granted a performance stock award that vests based on the achievement of certain performance conditions over a five-year timeframe from 2016 through December 31, 2020 and continued employment. On May 14, 2018, the performance conditions applicable to 33,750 shares were achieved and such shares will vest on May 20, 2018.